Vanta Bioscience Limited (VANTABIO.BO)
INR 42.57
(0.0%)
INR 42.57
(0.0%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 75.2 Million INR | 5.07% |
| 2022 | 71.57 Million INR | -1.08% |
| 2021 | 72.35 Million INR | -25.9% |
| 2020 | 97.64 Million INR | -30.29% |
| 2019 | 140.07 Million INR | 51.53% |
| 2018 | 92.44 Million INR | 205.65% |
| 2017 | 30.24 Million INR | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 Q4 | 75.2 Million INR | 5.8% |
| 2023 FY | 75.2 Million INR | 5.07% |
| 2023 Q2 | 71.08 Million INR | -0.69% |
| 2022 Q4 | 71.57 Million INR | -1.96% |
| 2022 Q2 | 73 Million INR | 0.9% |
| 2022 FY | 71.57 Million INR | -1.08% |
| 2021 FY | 72.35 Million INR | -25.9% |
| 2021 Q2 | 97.66 Million INR | 0.02% |
| 2021 Q4 | 72.35 Million INR | -25.91% |
| 2020 Q2 | 155.74 Million INR | 11.19% |
| 2020 FY | 97.64 Million INR | -30.29% |
| 2020 Q4 | 97.64 Million INR | -37.31% |
| 2019 Q4 | 140.07 Million INR | 19.79% |
| 2019 FY | 140.07 Million INR | 51.53% |
| 2019 Q2 | 116.92 Million INR | 26.49% |
| 2018 FY | 92.44 Million INR | 205.65% |
| 2018 Q4 | 92.44 Million INR | 62.27% |
| 2018 Q2 | 56.96 Million INR | 88.35% |
| 2017 FY | 30.24 Million INR | 0.0% |
| 2017 Q4 | 30.24 Million INR | 1262.98% |
| 2017 Q2 | 2.21 Million INR | 0.0% |
| 2016 Q4 | - INR | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Alfavision Overseas (India) Limited | - INR | -Infinity% |
| Biocon Limited | 49.43 Billion INR | 99.848% |
| Blue Jet Healthcare Limited | 1.29 Billion INR | 94.208% |
| Concord Biotech Limited | 2.07 Billion INR | 96.384% |
| Dishman Carbogen Amcis Limited | 8.82 Billion INR | 99.148% |
| FERMENTA BIOTECH LIMITED | 890.74 Million INR | 91.557% |
| GENOMIC VALLEY BIOTECH LIMITED | 1.00 INR | -7520599900.0% |
| Lyka Labs Limited | 95.71 Million INR | 21.43% |
| Panacea Biotec Limited | 1.77 Billion INR | 95.774% |
| SAMSRITA LABS LIMITED | 1.00 INR | -7520599900.0% |
| Servoteach Industries Limited | - INR | -Infinity% |
| SMS Lifesciences India Limited | 812.1 Million INR | 90.739% |
| Supriya Lifescience Limited | 852.49 Million INR | 91.178% |
| Syngene International Limited | 2.38 Billion INR | 96.847% |
| TAKE Solutions Limited | 7.96 Million INR | -844.799% |
| Titan Biotech Limited | 455.71 Million INR | 83.497% |
| Transgene Biotek Limited | 339 Thousand INR | -22084.661% |